# Early-Bank Semantic Audit: Currency Session 06

```text
AUDIT SESSION HEADER
====================
Session ID         : 2026-06-13-Currency-06
Reviewing Model    : OpenAI GPT-5.4 (non-Claude reviewer)
Questions Audited  : 4 Medium-provenance Claude case-study parts covering
                     teach-back, interdisciplinary discharge planning,
                     rivaroxaban safety, and C. difficile precautions
Total in Scope     : 4
Audit Categories   : OG
Track / Filter     : Currency; Medium provenance; remaining Claude-produced
                     items
Total Findings     : 0
  HIGH confidence  : 0
  MEDIUM confidence: 0
  LOW confidence   : 0
Null Ranges        : All 4 IDs produced no finding meeting the evidentiary
                     standard.
```

## No Finding

No finding meeting the evidentiary standard was identified for:

- `opus1_case_tha_discharge_lep_01_q2`
- `opus1_case_tha_discharge_lep_01_q3`
- `opus1_case_tha_discharge_lep_01_q4`
- `opus20_case_cdiff_01_q2`

The four items remain internally and clinically coherent in their full parent
case context:

- A failed teach-back appropriately prevents discharge-readiness clearance
  until the teaching method changes and understanding is demonstrated with
  qualified language support.
- The interdisciplinary plan appropriately addresses mobility, stairs,
  equipment, home support, home health, language access, medication safety,
  and final reassessment rather than treating stable vital signs as sufficient
  for discharge.
- Rivaroxaban 10 mg once daily for 35 days is the current labeled regimen
  after hip replacement. The 10 mg dose may be taken with or without food.
  The case appropriately asks the nurse to report and hand off the transient
  renal trend rather than independently stopping the prescribed
  anticoagulant. At the documented renal function, the item does not teach a
  contraindicated regimen.
- The C. difficile item appropriately interrupts a Contact Precautions breach,
  requires gown and gloves before reentry, and uses soap-and-water handwashing
  after the visitors touched the patient and immediate environment.

Current sources:

- FDA Xarelto prescribing information, 2025:
  https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022406s044%2C215859s005lbl.pdf
- HHS Office for Civil Rights, Section 1557 language-access provisions:
  https://www.hhs.gov/sites/default/files/ocr-dcl-section-1557-language-access.pdf
- AHRQ, Use the Teach-Back Method:
  https://www.ahrq.gov/health-literacy/improve/precautions/tool5.html
- CMS discharge-planning rule summary:
  https://www.cms.gov/newsroom/fact-sheets/cms-discharge-planning-rule-supports-interoperability-and-patient-preferences
- CDC C. difficile clinical overview:
  https://www.cdc.gov/c-diff/hcp/clinical-overview/index.html
- CDC hand-hygiene guidance:
  https://www.cdc.gov/clean-hands/hcp/clinical-safety/index.html

Alternative Interpretation:
The case gives the transient creatinine change substantial attention even
though the value returns toward baseline and the labeled prophylaxis regimen
remains usable. That emphasis is educationally defensible because the matrix
tests role boundaries, trend communication, adherence, bleeding surveillance,
and handoff rather than asserting that the nurse should stop therapy.

Recommendation: DISMISS all four Layer A routing signals. No patch or cut is
proposed.
